Global Rare Disease Genetic Testing Market Size, Share Analysis Report, 2024-2032

Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type; By Technology; By Speciality; By End-Use (Research Laboratories & Cros, Hospitals & Clinics, Diagnostic Laboratories); By Region; Segment Forecast, 2024 - 2032

Published Date:Jan-2024
Pages: 116
Format: PDF
Report ID: PM1772
Base Year: 2023
Historical Data: 2019-2022

Report Outlook

The global rare disease genetic testing market was valued at USD 334.7 million in 2023 and is expected to grow at a CAGR of 12.70% during the forecast period.

The rare disease genetic testing market has witnessed significant growth in recent years due to advancements in genetic testing technologies and increased awareness about rare genetic disorders. Rare diseases, also known as orphan diseases, are a group of conditions that affect a small percentage of the population. Genetic mutations often cause these diseases and can be challenging to diagnose and treat.

Rare Disease Genetic Testing Market Size

To Understand More About this Research: Request a Free Sample Report

Genetic testing plays a crucial role in identifying and diagnosing rare diseases. It involves analyzing an individual's DNA to detect any genetic variations or mutations responsible for their symptoms. The testing process typically includes DNA sequencing, molecular analysis, and other techniques to identify specific congenital abnormalities associated with rare diseases.

Several factors driving the market include advancements in DNA sequencing technologies, such as next-generation sequencing (NGS), which have made genetic testing more accessible and cost-effective. This has enabled healthcare providers to offer comprehensive genetic testing panels that can analyze multiple genes simultaneously, improving diagnostic accuracy for rare diseases.

The increasing prevalence of rare diseases and the rising demand for early and accurate diagnosis fuel the market growth. Many rare diseases have a genetic basis, and early detection can significantly impact patient outcomes by facilitating timely interventions and appropriate disease management strategies.

The COVID-19 pandemic has had mixed effects on the market. On the positive side, there has been an increased focus on personalized medicine and targeted therapies, with genetic testing playing a crucial role in identifying rare genetic disorders and guiding customized treatments. The pandemic has also accelerated the adoption of telemedicine, enabling at-home testing and virtual genetic counseling for individuals with rare diseases.

However, there have also been negative impacts, including disruptions in healthcare services leading to delayed diagnosis and testing, supply chain disruptions causing delays and increased costs, financial constraints affecting affordability and accessibility of testing, and research disruptions slowing down the development of new technologies and interventions.

Rare Disease Genetic Testing

Industry Dynamics

Growth Drivers

Technological advancements and next-generation sequencing (NGS)

The rare disease genetic testing market is experiencing growth driven by technological advancements in genetic testing, particularly next-generation sequencing (NGS), which has greatly enhanced the accuracy, speed, and cost-effectiveness of genetic testing. These advancements enable laboratories to analyze multiple genes simultaneously, improving the detection of rare genetic variants.

The increasing prevalence of rare diseases worldwide has spurred the demand for genetic testing. As rare diseases often have a genetic basis and can be challenging to diagnose through traditional methods, genetic testing plays a vital role in accurately identifying and diagnosing these disorders. The growing awareness of rare diseases and their genetic components has led healthcare providers to incorporate genetic testing into their diagnostic and treatment decision-making processes.

Another significant driver is the rise of personalized medicine and targeted therapies. Genetic testing allows healthcare professionals to identify specific genetic mutations or variations responsible for rare diseases, facilitating personalized treatment strategies tailored to individual patients. This approach improves treatment outcomes, reduces adverse effects, and optimizes patient care. Additionally, the demand for early diagnosis of rare diseases has fueled the adoption of genetic testing. Early identification enables timely interventions, appropriate treatment planning, and genetic counseling for patients and their families. By facilitating early diagnosis, genetic testing contributes to more effective disease management and improved patient outcomes.

Supportive regulatory environments have also played a role in the market's growth. Governments and regulatory bodies have recognized the importance of genetic testing in rare diseases, implementing policies and regulations to streamline approval processes, ensure quality standards, and promote research and development. These initiatives have fostered innovation and expanded access to genetic testing services.

Also, increasing awareness and patient advocacy efforts have heightened the recognition of genetic testing's value in rare diseases. Patient organizations, healthcare professionals, and advancements in media and communication have raised awareness about rare diseases and the role of genetic testing. This has increased the demand for genetic testing services among patients, healthcare providers, and the general public.

Report Segmentation

The market is primarily segmented based on disease type, technology, specialty, end-use, and region.

By Disease Type	By Technology	By Speciality	By End-Use	By Region
Neurological Disease Immunological Disorders Hematology Diseases Endocrine & Metabolism Diseases Cancer Musculoskeletal Disorders Cardiovascular Disorders Dermatology Disease Others	Next-Generation Sequencing Whole Exome Whole Genome Array Technology PCR-based Testing FISH Sanger Sequencing Karyotyping	Molecular Genetic Tests Chromosomal Genetic Tests Biochemical, Genetic Tests	Research Laboratories & Cros Hospitals & Clinics Diagnostic Laboratories	North America (U.S., Canada) Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia) Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) Latin America (Brazil, Mexico, Argentina) Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

To Understand the Scope of this Report: Speak to Analyst

By Disease Type Analysis

Endocrine and metabolism diseases segment accounted for the significant market share in 2022

The endocrine and metabolism diseases segment held the significant market share in 2022. The segment's growth was driven by the increasing demand for understanding the molecular and genetic causes of endocrine diseases like Cushing's syndrome. Additionally, identifying inherited mutations in primary pigmented nodular adrenocortical disease and bilateral macronodular adrenal hyperplasia is expected to boost this segment's progress further.

The immunological disorders segment is projected to have the highest revenue share. Multiple Sclerosis (MS), one of the most prevalent rare diseases, contributes significantly to this segment. Researchers in this field are particularly focused on studying the genetic profile of MS and gaining valuable insights into the underlying causes and physiology of the disease, which in turn drives market growth.

By Technology Analysis

Next-generation sequencing segment is anticipated to hold significant market share over forecast period

The next-generation sequencing segment is expected to hold a significant market share. Adopting next-generation sequencing-based gene panels for various applications such as neurologic disease, cancer, pediatric conditions, cardiovascular disease, psychiatric disorders, and other disease testing has been a key driver for the segment's growth.

Next-generation sequencing is classified into two categories whole exome and genome sequencing. The increasing acceptance of whole exome sequencing-based gene tests in the medical field has played a crucial role in advancing next-generation sequencing technology, thereby driving the growth of the rare disease genetic testing market.

By Speciality Analysis

Molecular genetic test segment is expected to grow fastest in the market during forecast period

The molecular genetic tests segment is anticipated to grow fastest in the market. This growth is attributed to technological advancements and expertise in managing high-throughput technologies in clinical settings. Molecular genetic testing techniques are employed to identify mutations or other abnormalities that cause genetic illnesses. These techniques focus on analyzing single genes and short lengths of DNA, making them suitable for rare and ultra-rare diseases. This factor is expected to drive the market for rare disease genetic testing and contribute to expanding the molecular genetic tests segment.

Genome sequencing emerged as the most widely used advanced testing technique. It is readily available in research and clinical settings, thanks to low-cost sequencing tests. This accessibility promotes the development of new tests based on next-generation sequencing technology.

Furthermore, the biochemical and genetic tests segment is projected to experience rapid growth during the forecast period. This segment can identify alterations in DNA that could lead to metabolic diseases and assess the quantity, activity, and associated abnormalities of proteins.

Rare Disease Genetic Testing Seg

By End-Use Analysis

Research Laboratories & CROs segment hold the largest revenue share in 2022

Research labs and Contract Research Organizations (CROs) hold the largest revenue share in the market. These entities serve as significant contributors to the market. Laboratories, in particular, are key end users and offer a wide range of testing specialties, including molecular, chromosomal, and biochemical genetic tests.

The demand for molecular genetic testing-based laboratory testing is rapidly expanding globally. Many laboratories, including those approved by the Clinical Laboratory Improvement Amendments (CLIA), provide genetic testing services across various areas such as clinical cytogenetics, pathology, and chemistry.

Moreover, the diagnostic laboratories segment is expected to grow fastest during the forecast period. This growth can be attributed to the increasing collaborations and partnerships between diagnostic laboratories and genetic testing companies, which further drive advancements and accessibility in rare disease genetic testing.

Regional Insights

North America is anticipated to hold the largest market share over forecast period

North America is projected to hold the largest market share during the forecast period due to the increasing prevalence of rare diseases, numerous disease registries, a significant number of research and development centers focused on ultra-rare diseases, and substantial investments in disease detection.

According to the National Institutes of Health, there are over 7,000 rare diseases, and nearly 30 million Americans have been diagnosed with one or more of these conditions. The rise in the number of patients undergoing disease testing has significantly contributed to the market growth in this region.

Key Market Players & Competitive Insight

The increasing recognition of the clinical utility of genetic testing for diagnosing and managing rare diseases. Key players are expanding their genetic testing portfolios and geographic reach through strategic acquisitions and partnerships. Advancements in next-generation sequencing (NGS) technologies have lowered the cost and improved the accuracy of genetic testing. As the demand for early and accurate rare disease diagnosis continues to rise, competition remains fierce in delivering innovative genetic testing solutions, customizing therapies, and optimizing patient outcomes.

Rare Disease Genetic Testing Reg

Some of the major players operating in the global market include:

3billion, Inc.
Ambry Genetics
Arup Laboratories
Artemis DNA
Centogene N.V.
Color Genomics, Inc.
Coopersurgical, Inc.
Eurofins Scientific
Fulgent Genetics Inc.
Genomenon
Health Network Laboratories
Invitae Corp.
Laboratory Corporation of America Holdings
Macrogen, Inc.
Myriad Genetics, Inc.
OPKO Health, Inc.
PerkinElmer, Inc.
PreventionGenetics
Progenity, Inc.
Quest Diagnostics Inc.
Realm IDX, Inc.
Strand Life Sciences

Recent Developments

In February 2022, Bionano Genomics has recently introduced the Rare Undiagnosed Genetic Disease (RUGD) initiative, aiming to enhance the commitment and emphasis on clinical and translational research.
In November 2021, Genomenon collaborated with Alexion to empower the genetic testing laboratories with the data they need to diagnose rare diseases.

Rare Disease Genetic Testing Market Report Scope

Report Attributes	Details
Market size value in 2024	USD 374.7 million
Revenue forecast in 2032	USD 3,102.4 million
CAGR	13.4% from 2024 – 2032
Base year	2023
Historical data	2019 – 2022
Forecast period	2024 – 2032
Quantitative units	Revenue in USD million and CAGR from 2024 to 2032
Segments Covered	By Disease Type, By Technology, By Speciality, By End-Use, By Region
Regional scope	North America, Europe, Asia Pacific, Latin America; Middle East & Africa
Customization	Report customization as per your requirements with respect to countries, region and segmentation.

FAQ's

Who are the key companies in rare disease genetic testing market?

key companies in rare disease genetic testing market are Opko Health, Inc., Arup Laboratories, Color Genomics, Inc., PreventionGenetics, Centogene N.V.

What is the CAGR estimated to be calculated for the rare disease genetic testing market?

The global rare disease genetic testing market is expected to grow at a CAGR of 13.4% during the forecast period.

What are the key segments covered?

The rare disease genetic testing market report covering key segments are disease type, technology, specialty, end-use, and region.

What are the key driving factors in industrial rare disease genetic testing market?

key driving factors in industrial rare disease genetic testing market are technological advancements and next-generation sequencing (NGS).

What will be the market value estimated by the end of 2032?

The global Rare Disease Genetic Testing market size is expected to reach USD 3,102.4 million by 2032.

1. Introduction
              1.1. Report Description
                    1.1.1. Objectives of the Study
                    1.1.2. Market Scope
                    1.1.3. Assumptions
              1.2. Stakeholders
2. Executive Summary
              2.1. Market Highlights
3. Research Methodology
              3.1. Overview
                    3.1.1. Data Mining
              3.2. Data Sources
                    3.2.1. Primary Sources
                    3.2.2. Secondary Sources
4. Global Rare Disease Genetic Testing Market Insights
              4.1. Rare Disease Genetic Testing – Industry Snapshot
              4.2. Rare Disease Genetic Testing Market Dynamics
                    4.2.1. Drivers and Opportunities
                            4.2.1.1. Technological advancements and next-generation sequencing (NGS)
                            4.2.1.2. Personalized medicine and early diagnosis
                    4.2.2. Restraints and Challenges
                            4.2.2.1. Challenges in reimbursement and accessibility
              4.3. Porter’s Five Forces Analysis
                    4.3.1. Bargaining Power of Suppliers (Moderate)
                    4.3.2. Threats of New Entrants: (Low)
                    4.3.3. Bargaining Power of Buyers (Moderate)
                    4.3.4. Threat of Substitute (Moderate)
                    4.3.5. Rivalry among existing firms (High)
              4.4. PESTLE Analysis
              4.5. Rare Disease Genetic Testing Industry Trends
              4.6. Value Chain Analysis
              4.7. COVID-19 Impact Analysis
5. Global Rare Disease Genetic Testing Market, by Technology
              5.1. Key Findings
              5.2. Introduction
                    5.2.1. Global Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
              5.3. Next-Generation Sequencing
                    5.3.1. Global Rare Disease Genetic Testing Market, by Next-Generation Sequencing, by Region, 2019 - 2032 (USD Million)
                    5.3.2. Whole Exome
                            5.3.2.1. Global Rare Disease Genetic Testing Market, by Whole Exome, by Region, 2019 - 2032 (USD Million)
                    5.3.3. Whole Genome
                            5.3.3.1. Global Rare Disease Genetic Testing Market, by Whole Genome, by Region, 2019 - 2032 (USD Million)
              5.4. Array Technology
                    5.4.1. Global Rare Disease Genetic Testing Market, by Array Technology, by Region, 2019 - 2032 (USD Million)
              5.5. PCR-based Testing
                    5.5.1. Global Rare Disease Genetic Testing Market, by PCR-based Testing, by Region, 2019 - 2032 (USD Million)
              5.6. FISH
                    5.6.1. Global Rare Disease Genetic Testing Market, by FISH, by Region, 2019 - 2032 (USD Million)
              5.7. Sanger Sequencing
                    5.7.1. Global Rare Disease Genetic Testing Market, by Sanger Sequencing, by Region, 2019 - 2032 (USD Million)
              5.8. Karyotyping
                    5.8.1. Global Rare Disease Genetic Testing Market, by Karyotyping, by Region, 2019 - 2032 (USD Million)
6. Global Rare Disease Genetic Testing Market, by Specialty
              6.1. Key Findings
              6.2. Introduction
                    6.2.1. Global Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
              6.3. Molecular Genetic Tests
                    6.3.1. Global Rare Disease Genetic Testing Market, by Molecular Genetic Tests, by Region, 2019 - 2032 (USD Million)
              6.4. Chromosomal Genetic Tests
                    6.4.1. Global Rare Disease Genetic Testing Market, by Chromosomal Genetic Tests, by Region, 2019 - 2032 (USD Million)
              6.5. Biochemical, Genetic Tests
                    6.5.1. Global Rare Disease Genetic Testing Market, by Biochemical, Genetic Tests, by Region, 2019 - 2032 (USD Million)
7. Global Rare Disease Genetic Testing Market, by Disease Type
              7.1. Key Findings
              7.2. Introduction
                    7.2.1. Global Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
              7.3. Neurological Disease
                    7.3.1. Global Rare Disease Genetic Testing Market, by Neurological Disease, by Region, 2019 - 2032 (USD Million)
              7.4. Immunological Disorders
                    7.4.1. Global Rare Disease Genetic Testing Market, by Immunological Disorders, by Region, 2019 - 2032 (USD Million)
              7.5. Hematology Diseases
                    7.5.1. Global Rare Disease Genetic Testing Market, by Hematology Diseases, by Region, 2019 - 2032 (USD Million)
              7.6. Endocrine & Metabolism Diseases
                    7.6.1. Global Rare Disease Genetic Testing Market, by Endocrine & Metabolism Diseases, by Region, 2019 - 2032 (USD Million)
              7.7. Cancer
                    7.7.1. Global Rare Disease Genetic Testing Market, by Cancer, by Region, 2019 - 2032 (USD Million)
              7.8. Musculoskeletal Disorders
                    7.8.1. Global Rare Disease Genetic Testing Market, by Musculoskeletal Disorders, by Region, 2019 - 2032 (USD Million)
              7.9. Cardiovascular Disorders
                    7.9.1. Global Rare Disease Genetic Testing Market, by Cardiovascular Disorders, by Region, 2019 - 2032 (USD Million)
              7.10. Dermatology Disease
                    7.10.1. Global Rare Disease Genetic Testing Market, by Dermatology Disease, by Region, 2019 - 2032 (USD Million)
              7.11. Others
                    7.11.1. Global Other Rare Disease Genetic Testing Market, by Region, 2019 - 2032 (USD Million)
8. Global Rare Disease Genetic Testing Market, by End-use
              8.1. Key Findings
              8.2. Introduction
                    8.2.1. Global Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
              8.3. Research Laboratories & Cros
                    8.3.1. Global Rare Disease Genetic Testing Market, by Research Laboratories & Cros, by Region, 2019 - 2032 (USD Million)
              8.4. Hospitals & Clinics
                    8.4.1. Global Rare Disease Genetic Testing Market, by Hospitals & Clinics, by Region, 2019 - 2032 (USD Million)
              8.5. Diagnostic Laboratories
                    8.5.1. Global Rare Disease Genetic Testing Market, by Diagnostic Laboratories, by Region, 2019 - 2032 (USD Million)
9. Global Rare Disease Genetic Testing Market, by Geography
              9.1. Key findings
              9.2. Introduction
                    9.2.1. Rare Disease Genetic Testing Market Assessment, By Geography, 2019 - 2032 (USD Million)
              9.3. Rare Disease Genetic Testing Market – North America
                    9.3.1. North America: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                    9.3.2. North America: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                    9.3.3. North America: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                    9.3.4. North America: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.3.5. Rare Disease Genetic Testing Market – U.S.
                                          9.3.5.1. U.S.: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                                          9.3.5.2. U.S.: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                                          9.3.5.3. U.S.: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                                          9.3.5.4. U.S.: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.3.6. Rare Disease Genetic Testing Market – Canada
                            9.3.6.1. Canada: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.3.6.2. Canada: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.3.6.3. Canada: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.3.6.4. Canada: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
              9.4. Rare Disease Genetic Testing Market – Europe
                    9.4.1. Europe: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                    9.4.2. Europe: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                    9.4.3. Europe: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                    9.4.4. Europe: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.4.5. Rare Disease Genetic Testing Market – UK
                            9.4.5.1. UK: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.4.5.2. UK: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.4.5.3. UK: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.4.5.4. UK: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.4.6. Rare Disease Genetic Testing Market – France
                            9.4.6.1. France: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.4.6.2. France: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.4.6.3. France: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.4.6.4. France: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.4.7. Rare Disease Genetic Testing Market – Germany
                            9.4.7.1. Germany: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.4.7.2. Germany: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.4.7.3. Germany: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.4.7.4. Germany: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.4.8. Rare Disease Genetic Testing Market – Italy
                            9.4.8.1. Italy: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.4.8.2. Italy: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.4.8.3. Italy: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.4.8.4. Italy: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.4.9. Rare Disease Genetic Testing Market – Spain
                            9.4.9.1. Spain: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.4.9.2. Spain: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.4.9.3. Spain: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.4.9.4. Spain: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.4.10. Rare Disease Genetic Testing Market – Netherlands
                            9.4.10.1. Netherlands: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.4.10.2. Netherlands: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.4.10.3. Netherlands: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.4.10.4. Netherlands: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.4.11. Rare Disease Genetic Testing Market – Russia
                            9.4.11.1. Russia: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                                  9.4.11.2. Russia.: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.4.11.3. Russia: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.4.11.4. Russia: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
              9.5. Rare Disease Genetic Testing Market – Asia Pacific
                    9.5.1. Asia Pacific: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                    9.5.2. Asia Pacific: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                    9.5.3. Asia Pacific: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                    9.5.4. Asia Pacific: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.5.5. Rare Disease Genetic Testing Market – China
                            9.5.5.1. China: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                                  9.5.5.2. China.: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.5.5.3. China: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.5.5.4. China: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.5.6. Rare Disease Genetic Testing Market – India
                            9.5.6.1. India: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                                  9.5.6.2. India.: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.5.6.3. India: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.5.6.4. India: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.5.7. Rare Disease Genetic Testing Market – Japan
                            9.5.7.1. Japan: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                                  9.5.7.2. Japan.: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.5.7.3. Japan: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.5.7.4. Japan: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.5.8. Rare Disease Genetic Testing Market – Malaysia
                            9.5.8.1. Malaysia: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                                  9.5.8.2. Malaysia.: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.5.8.3. Malaysia: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.5.8.4. Malaysia: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.5.9. Rare Disease Genetic Testing Market – Indonesia
                            9.5.9.1. Indonesia: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                                  9.5.9.2. Indonesia.: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.5.9.3. Indonesia: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.5.9.4. Indonesia: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.5.10. Rare Disease Genetic Testing Market – South Korea
                            9.5.10.1. South Korea: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.5.10.2. South Korea.: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.5.10.3. South Korea: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.5.10.4. South Korea: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
              9.6. Rare Disease Genetic Testing Market – Middle East & Africa
                    9.6.1. Middle East & Africa: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                    9.6.2. Middle East & Africa: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                    9.6.3. Middle East & Africa: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                    9.6.4. Middle East & Africa: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.6.5. Rare Disease Genetic Testing Market – Saudi Arabia
                            9.6.5.1. Saudi Arabia: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.6.5.2. Saudi Arabia: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.6.5.3. Saudi Arabia: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.6.5.4. Saudi Arabia: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.6.6. Rare Disease Genetic Testing Market – South Africa
                            9.6.6.1. South Africa: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.6.6.2. South Africa: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.6.6.3. South Africa: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.6.6.4. South Africa: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.6.7. Rare Disease Genetic Testing Market – Israel
                            9.6.7.1. Israel: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.6.7.2. Israel: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.6.7.3. Israel: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.6.7.4. Israel: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.6.8. Rare Disease Genetic Testing Market – UAE
                            9.6.8.1. UAE: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.6.8.2. UAE: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.6.8.3. UAE: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.6.8.4. UAE: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
              9.7. Rare Disease Genetic Testing Market – Latin America
                    9.7.1. Latin America: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                    9.7.2. Latin America: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                    9.7.3. Latin America: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                    9.7.4. Latin America: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.7.5. Rare Disease Genetic Testing Market – Mexico
                            9.7.5.1. Mexico: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.7.5.2. Mexico: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.7.5.3. Mexico: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.7.5.4. Mexico: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.7.6. Rare Disease Genetic Testing Market – Brazil
                            9.7.6.1. Brazil: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.7.6.2. Brazil: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.7.6.3. Brazil: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.7.6.4. Brazil: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
                    9.7.7. Rare Disease Genetic Testing Market – Argentina
                            9.7.7.1. Argentina: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
                            9.7.7.2. Argentina: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
                            9.7.7.3. Argentina: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
                            9.7.7.4. Argentina: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
10. Competitive Landscape
              10.1. Expansion and Acquisition Analysis
                    10.1.1. Expansion
                    10.1.2. Acquisitions
              10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
              11.1. 3billion, Inc
                    11.1.1. Company Overview
                    11.1.2. Financial Performance
                    11.1.3. Product Benchmarking
                    11.1.4. Recent Development
              11.2. Ambry Genetics
                    11.2.1. Company Overview
                    11.2.2. Financial Performance
                    11.2.3. Product Benchmarking
                    11.2.4. Recent Development
              11.3. Artemis DNA
                    11.3.1. Company Overview
                    11.3.2. Financial Performance
                    11.3.3. Product Benchmarking
                    11.3.4. Recent Development
              11.4. Arup Laboratories
                    11.4.1. Company Overview
                    11.4.2. Financial Performance
                    11.4.3. Product Benchmarking
                    11.4.4. Recent Development
              11.5. Centogene N.V
                    11.5.1. Company Overview
                    11.5.2. Financial Performance
                    11.5.3. Product Benchmarking
                    11.5.4. Recent Development
              11.6. Color Genomics, Inc
                    11.6.1. Company Overview
                    11.6.2. Financial Performance
                    11.6.3. Product Benchmarking
                    11.6.4. Recent Development
              11.7. Coopersurgical, Inc
                    11.7.1. Company Overview
                    11.7.2. Financial Performance
                    11.7.3. Product Benchmarking
                    11.7.4. Recent Development
              11.8. Eurofins Scientific
                    11.8.1. Company Overview
                    11.8.2. Financial Performance
                    11.8.3. Product Benchmarking
                    11.8.4. Recent Development
              11.9. Fulgent Genetics Inc
                    11.9.1. Company Overview
                    11.9.2. Financial Performance
                    11.9.3. Product Benchmarking
                    11.9.4. Recent Development
              11.10. Genomenon
                    11.10.1. Company Overview
                    11.10.2. Financial Performance
                    11.10.3. Product Benchmarking
                    11.10.4. Recent Development
              11.11. Health Network Laboratories
                    11.11.1. Company Overview
                    11.11.2. Financial Performance
                    11.11.3. Product Benchmarking
                    11.11.4. Recent Development
              11.12. Invitae Corp
                    11.12.1. Company Overview
                    11.12.2. Financial Performance
                    11.12.3. Product Benchmarking
                    11.12.4. Recent Development
              11.13. Laboratory Corporation of America Holdings
                    11.13.1. Company Overview
                    11.13.2. Financial Performance
                    11.13.3. Product Benchmarking
                    11.13.4. Recent Development
              11.14. Macrogen, Inc
                    11.14.1. Company Overview
                    11.14.2. Financial Performance
                    11.14.3. Product Benchmarking
                    11.14.4. Recent Development
              11.15. Myriad Genetics, Inc.
                    11.15.1. Company Overview
                    11.15.2. Financial Performance
                    11.15.3. Product Benchmarking
                    11.15.4. Recent Development
              11.16. Opko Health, Inc
                    11.16.1. Company Overview
                    11.16.2. Financial Performance
                    11.16.3. Product Benchmarking
                    11.16.4. Recent Development
              11.17. Perkin Elmer, Inc
                    11.17.1. Company Overview
                    11.17.2. Financial Performance
                    11.17.3. Product Benchmarking
                    11.17.4. Recent Development
              11.18. PreventionGenetics
                    11.18.1. Company Overview
                    11.18.2. Financial Performance
                    11.18.3. Product Benchmarking
                    11.18.4. Recent Development
              11.19. Progenity, Inc
                    11.19.1. Company Overview
                    11.19.2. Financial Performance
                    11.19.3. Product Benchmarking
                    11.19.4. Recent Development
              11.20. Quest Diagnostics Inc.
                    11.20.1. Company Overview
                    11.20.2. Financial Performance
                    11.20.3. Product Benchmarking
                    11.20.4. Recent Development
              11.21. Realm IDX, Inc
                    11.21.1. Company Overview
                    11.21.2. Financial Performance
                    11.21.3. Product Benchmarking
                    11.21.4. Recent Development
              11.22. Strand Life Sciences.
                    11.22.1. Company Overview
                    11.22.2. Financial Performance
                    11.22.3. Product Benchmarking
                    11.22.4. Recent Development

List of Tables

Table 1 Global Rare Disease Genetic Testing Market, by Technology, by Region, 2019 - 2032 (USD Million)
Table 2 Global Rare Disease Genetic Testing Market, by Specialty, by Region, 2019 - 2032 (USD Million)
Table 3 Global Rare Disease Genetic Testing Market, by Disease Type, by Region, 2019 - 2032 (USD Million)
Table 4 Global Rare Disease Genetic Testing Market, by End-use, by Region, 2019 - 2032 (USD Million)
Table 5 Rare Disease Genetic Testing Market Assessment, By Geography, 2019 - 2032 (USD Million)
Table 6 North America: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 7 North America: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 8 North America: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 9 North America: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 10 U.S.: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 11 U.S.: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 12 U.S.: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 13 U.S.: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 14 Canada: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 15 Canada: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 16 Canada: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 17 Canada: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 18 Europe: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 19 Europe: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 20 Europe: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 21 Europe: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 22 Germany: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 23 Germany: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 24 Germany: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 25 Germany: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 26 France: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 27 France: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 28 France: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 29 France: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 30 UK: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 31 UK: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 32 UK: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 33 UK: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 34 Italy: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 35 Italy: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 36 Italy: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 37 Italy: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 38 Netherlands: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 39 Netherlands: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 40 Netherlands: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 41 Netherlands: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 42 Spain: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 43 Spain: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 44 Spain: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 45 Spain: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 46 Russia: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 47 Russia: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 48 Russia: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 49 Russia: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 50 Asia Pacific: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 51 Asia Pacific: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 52 Asia Pacific: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 53 Asia Pacific: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 54 China: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 55 China: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 56 China: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 57 China: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 58 Japan: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 59 Japan: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 60 Japan: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 61 Japan: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 62 India: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 63 India: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 64 India: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 65 India: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 66 Indonesia: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 67 Indonesia: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 68 Indonesia: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 69 Indonesia: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 70 Malaysia: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 71 Malaysia: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 72 Malaysia: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 73 Malaysia: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 74 South Korea: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 75 South Korea: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 76 South Korea: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 77 South Korea: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 78 Latin America: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 79 Latin America: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 80 Latin America: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 81 Latin America: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 82 Brazil: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 83 Brazil: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 84 Brazil: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 85 Brazil: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)
Table 86 Mexico: Rare Disease Genetic Testing Market, by Technology, 2019 - 2032 (USD Million)
Table 87 Mexico: Rare Disease Genetic Testing Market, by Specialty, 2019 - 2032 (USD Million)
Table 88 Mexico: Rare Disease Genetic Testing Market, by Disease Type, 2019 - 2032 (USD Million)
Table 89 Mexico: Rare Disease Genetic Testing Market, by End-use, 2019 - 2032 (USD Million)

Report Scope

Rare Disease Genetic Testing Market, Technology Outlook (Revenue - USD Million, 2019 - 2032)

Next-Generation Sequencing
- Whole Exome
- Whole Genome
Array Technology
PCR-based Testing
FISH
Sanger Sequencing
Karyotyping

Rare Disease Genetic Testing Market, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

Neurological Disease
Immunological Disorders
Hematology Diseases
Endocrine & Metabolism Diseases
Cancer
Musculoskeletal Disorders
Cardiovascular Disorders
Dermatology Disease
Others

Rare Disease Genetic Testing Market, Specialty Outlook (Revenue - USD Million, 2019 - 2032)

Molecular Genetic Tests
Chromosomal Genetic Tests
Biochemical, Genetic Tests

Rare Disease Genetic Testing Market, End-use Outlook (Revenue - USD Million, 2019 - 2032)

Research Laboratories & Cros
Hospitals & Clinics
Diagnostic Laboratories

Rare Disease Genetic Testing Market, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America
- Technology Outlook
  - Next-Generation Sequencing
    - Whole Exome
    - Whole Genome
  - Array Technology
  - PCR-based Testing
  - FISH
  - Sanger Sequencing
  - Karyotyping
- Disease Type Outlook
  - Neurological Disease
  - Immunological Disorders
  - Hematology Diseases
  - Endocrine & Metabolism Diseases
  - Cancer
  - Musculoskeletal Disorders
  - Cardiovascular Disorders
  - Dermatology Disease
  - Others
- Specialty Outlook
  - Molecular Genetic Tests
  - Chromosomal Genetic Tests
  - Biochemical, Genetic Tests
- End-use Outlook
  - Research Laboratories & Cros
  - Hospitals & Clinics
  - Diagnostic Laboratories
Europe
- Technology Outlook
  - Next-Generation Sequencing
    - Whole Exome
    - Whole Genome
  - Array Technology
  - PCR-based Testing
  - FISH
  - Sanger Sequencing
  - Karyotyping
- Disease Type Outlook
  - Neurological Disease
  - Immunological Disorders
  - Hematology Diseases
  - Endocrine & Metabolism Diseases
  - Cancer
  - Musculoskeletal Disorders
  - Cardiovascular Disorders
  - Dermatology Disease
  - Others
- Specialty Outlook
  - Molecular Genetic Tests
  - Chromosomal Genetic Tests
  - Biochemical, Genetic Tests
- End-use Outlook
  - Research Laboratories & Cros
  - Hospitals & Clinics
  - Diagnostic Laboratories
Asia Pacific
- Technology Outlook
  - Next-Generation Sequencing
    - Whole Exome
    - Whole Genome
  - Array Technology
  - PCR-based Testing
  - FISH
  - Sanger Sequencing
  - Karyotyping
- Disease Type Outlook
  - Neurological Disease
  - Immunological Disorders
  - Hematology Diseases
  - Endocrine & Metabolism Diseases
  - Cancer
  - Musculoskeletal Disorders
  - Cardiovascular Disorders
  - Dermatology Disease
  - Others
- Specialty Outlook
  - Molecular Genetic Tests
  - Chromosomal Genetic Tests
  - Biochemical, Genetic Tests
- End-use Outlook
  - Research Laboratories & Cros
  - Hospitals & Clinics
  - Diagnostic Laboratories
Latin America
- Technology Outlook
  - Next-Generation Sequencing
    - Whole Exome
    - Whole Genome
  - Array Technology
  - PCR-based Testing
  - FISH
  - Sanger Sequencing
  - Karyotyping
- Disease Type Outlook
  - Neurological Disease
  - Immunological Disorders
  - Hematology Diseases
  - Endocrine & Metabolism Diseases
  - Cancer
  - Musculoskeletal Disorders
  - Cardiovascular Disorders
  - Dermatology Disease
  - Others
- Specialty Outlook
  - Molecular Genetic Tests
  - Chromosomal Genetic Tests
  - Biochemical, Genetic Tests
- End-use Outlook
  - Research Laboratories & Cros
  - Hospitals & Clinics
  - Diagnostic Laboratories
Middle East & Africa
- Technology Outlook
  - Next-Generation Sequencing
    - Whole Exome
    - Whole Genome
  - Array Technology
  - PCR-based Testing
  - FISH
  - Sanger Sequencing
  - Karyotyping
- Disease Type Outlook
  - Neurological Disease
  - Immunological Disorders
  - Hematology Diseases
  - Endocrine & Metabolism Diseases
  - Cancer
  - Musculoskeletal Disorders
  - Cardiovascular Disorders
  - Dermatology Disease
  - Others
- Specialty Outlook
  - Molecular Genetic Tests
  - Chromosomal Genetic Tests
  - Biochemical, Genetic Tests
- End-use Outlook
  - Research Laboratories & Cros
  - Hospitals & Clinics
  - Diagnostic Laboratories

Qualitative Analysis

Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL Analysis
- Value Chain Analysis
- Key market opportunities prioritized
Competitive landscape
- Overview
- Financials
- Product benchmarking
- Latest strategic developments
- Price Trend Analysis

Quantitative Analysis

Market size, estimates, and forecasts from 2019 - 2032
Market size and revenue estimates for end-use up to 2032
Market revenue estimates for technology up to 2032
Market revenue estimates for disease type up to 2032
Market revenue estimates for specialty up to 2032
Regional market size and forecast up to 2032
Company financials

Request Free Sample

We take great pride in "Delivering game-changing business opportunities reports with report customizations", so please don't hesitate to share with us your unique interests and business difficulties in much more detail.

By using this form you agree with the storage and handling of your data by this website.

This website is secure and your personal details are safe. Privacy Policy

Global Rare Disease Genetic Testing Market Size, Share Analysis Report, 2024-2032

What's Included in Full Report?

Request Sample Report